Skip to main content
. 2023 Jun 7;9(6):e17080. doi: 10.1016/j.heliyon.2023.e17080

Fig. 1.

Fig. 1

Schematic representation of the molecular docking models of cyclooxygenase-2 (COX-2) binding with fulvic acid (FA) (A) and celecoxib (control, an inhibitor of COX-2) (B).